Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy
Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy
Recruiting · NCT03555851 · Registry updated 2026-07-13Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Factors Affecting Post-transplant Cyclophosphamide (PTCy) Efficacy | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, hematologic disorder, leukemia, neoplasm | Recruiting | Not stated | 2026-07-13 | NCT03555851 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Atrium Health Levine Cancer Institute | 27 |
| Wake Forest University Health Sciences | 284 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Levine Cancer Institute | Charlotte | United States | 110 |